Adam Carl Sukhija-Cohen

Dr. Adam Carl Sukhija-Cohen

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
ASAdam Carl Sukhija-Cohen
Adam Carl Sukhija-Cohen
HPHenna Patani
Henna Patani
ARAntigone Contessa Robinson
Antigone Contessa Robinson
MSMatthew Ramos Santos
Matthew Ramos Santos
YGYancy Granados
Yancy Granados
Among 98 participants with penile discharge symptoms of Chlamydia trachomatis or Neisseria gonorrhoeae at a walk-in sexual health clinic, 11 were diagnosed with Mycoplasma genitalium, 10 had antibiotic resistance, and 6 were incorrectly presumptively treated. Our findings highlight the importance of public health strategies and research to curb M genitalium.

23 October 2025 in Sexually Transmitted Infections
Verified
Journal Article
Closed access
PDF file
JKJosephine Yoolie Kim
Josephine Yoolie Kim
ASAdam Carl Sukhija-Cohen
Adam Carl Sukhija-Cohen
SSSuhail Abdeen Samidon
Suhail Abdeen Samidon
MRManda Beth Robinson
Manda Beth Robinson
MOMaria Jose Ordenana
Maria Jose Ordenana
MMMark Roy McGrath
Mark Roy McGrath
Objective: To evaluate the outcomes of a street medicine intervention offering syphilis testing and treatment to people experiencing homelessness in South Los Angeles, California—a population disproportionately affected by syphilis and underserved by traditional healthcare systems. Methods: From September 2024 to January 2025, a multidisciplinary street medicine team provided testing and treatment for syphilis during outreach visits to patients experiencing homelessness. A total of 99 patients were tested using the reverse syphilis testing algorithm. Demographic data included gender, race/ethnicity, substance use disorder, mental illness and HIV status. χ 2 tests were used to evaluate associations between syphilis diagnosis and each demographic characteristic. Results: Thirty-six (36.4%) of the 99 patients had reactive syphilis test results, with 94.4% (n=34) classified as late-stage infections. Of those diagnosed, 72.2% (n=26) were treated during follow-up visits. Statistically significant associations were found between syphilis diagnosis and gender (p=0.002), substance use disorder (p=0.008) and HIV status (p=0.020). Patients identifying as female or transgender female, and those with cooccurring substance use disorder or HIV, were more likely to be diagnosed with syphilis. Conclusions: This study demonstrates the feasibility and outcomes of delivering sexually transmitted infection care through street medicine. The high prevalence of late-stage syphilis and its syndemic overlap with substance use disorder and HIV underscores the need for low-barrier, community-based services. Street medicine interventions should be recognised and resourced as essential tools in public health responses to rising syphilis rates, particularly among unhoused populations.

2 October 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ASAdam Carl Sukhija-Cohen
Adam Carl Sukhija-Cohen
HPHenna Patani
Henna Patani
MBMichael Blasingame
Michael Blasingame
KVKathy Linh Vu
Kathy Linh Vu
RBRamin Bastani
Ramin Bastani
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Digital interventions to improve retention in HIV care are critical to ensure viral suppression and prevent further transmission. The AIDS Healthcare Foundation operates Healthcare Centers across the United States to provide primary HIV care. Traditionally, the Healthcare Centers conduct phone calls with patients to schedule and confirm appointments, as well as share laboratory results. In 2017, Healthvana piloted a digital platform at the AIDS Healthcare Foundation’s Healthcare Centers to send patients SMS text message appointment reminders and allow patients to review their upcoming appointment and view their laboratory results in the web-based patient portal. Objective: A national implementation in 15 US states and Washington, DC, of this digital intervention pilot by Healthvana aims to determine whether SMS appointment reminders and web-based patient portal logins improved retention in care compared to traditional methods. Methods: A retrospective analysis of 40,028 patients living with HIV was conducted at the AIDS Healthcare Foundation’s 61 Healthcare Centers between January 2, 2017, and May 22, 2018. Patients were invited to enroll in Healthvana’s digital intervention pilot, allowing for a natural, organization-wide case-control study. Separate binary logistic regression models evaluated the relationship between receiving SMS appointment reminders and completing scheduled appointments, as well as the relationship between logging into the web-based patient portal and completing scheduled appointments. Four scheduled consecutive appointments for each patient were included in the analysis to account for one full year of data per patient. Results: Patients who received the SMS appointment reminder were 1.7 times more likely to complete appointment 1 compared to patients who did not receive the SMS appointment reminder (P<.001). In addition, patients who received the SMS appointment reminder were 1.6 times more likely to complete appointment 2 (P<.001), 1.7 times more likely to complete appointment 3 (P<.001), and 1.8 times more likely to complete appointment 4 (P<.001) compared to patients who did not receive the SMS appointment reminder. Patients who logged in to the web-based patient portal prior to their scheduled appointment were 7.4 times more likely to complete appointment 1 compared to patients who did not log in (P<.001). In addition, patients who logged in to the web-based patient portal prior to their scheduled appointment were 3.6 times more likely to complete appointment 2 (P<.001), 3.2 times more likely to complete appointment 3 (P<.001), and 2.8 times more likely to complete appointment 4 (P<.001) compared to patients who did not log in. Conclusions: HIV primary care appointment completion was higher when patients engaged with Healthvana’s digital platform. Digital technology interventions to ensure patients complete their scheduled HIV care appointments are imperative to curb the HIV epidemic.

8 July 2024 in JMIR Preprints
Verified
Preprint
Open access
ASAdam Carl Sukhija-Cohen
Adam Carl Sukhija-Cohen
HPHenna Patani
Henna Patani
MBMichael Blasingame
Michael Blasingame
KVKathy Linh Vu
Kathy Linh Vu
RBRamin Bastani
Ramin Bastani
BACKGROUND Digital interventions to improve retention in HIV care are critical to ensure viral suppression and prevent further transmission. AIDS Healthcare Foundation Healthcare Centers are centers across the United States that provide primary HIV care. Traditionally, the Healthcare Centers conduct phone calls with patients to schedule and confirm appointments, as well as share laboratory results. In 2017, Healthvana piloted a digital platform at AIDS Healthcare Foundation Healthcare Centers to send patients SMS text message appointment reminders and allow patients to review their upcoming appointment and view their laboratory results in the web-based patient portal. OBJECTIVE A national implementation in 15 US states and Washington, DC, of this digital intervention pilot by Healthvana aims to determine whether SMS appointment reminders and web-based patient portal logins improved retention in care compared to traditional methods. METHODS A retrospective analysis of 40,028 patients living with HIV was conducted at the 61 AIDS Healthcare Foundation Healthcare Centers between January 2, 2017, and May 22, 2018. Patients were invited to enroll in Healthvana’s digital intervention pilot, allowing for a natural, organization-wide case-control study. Separate binary logistic regression models evaluated the relationship between receiving SMS appointment reminders and completing scheduled appointments, as well as the relationship between logging into the web-based patient portal and completing scheduled appointments. Four scheduled consecutive appointments for each patient were included in the analysis to account for 1 full year of data per patient. RESULTS Patients who received the SMS appointment reminder were 1.7 times more likely to complete appointment 1 compared to patients who did not receive the SMS appointment reminder (P<.001). In addition, patients who received the SMS appointment reminder were 1.6 times more likely to complete appointment 2 (P<.001), 1.7 times more likely to complete appointment 3 (P<.001), and 1.8 times more likely to complete appointment 4 (P<.001) compared to patients who did not receive the SMS appointment reminder. Patients who logged in to the web-based patient portal prior to their scheduled appointment were 7.4 times more likely to complete appointment 1 compared to patients who did not log in (P<.001). In addition, patients who logged in to the web-based patient portal prior to their scheduled appointment were 3.6 times more likely to complete appointment 2 (P<.001), 3.2 times more likely to complete appointment 3 (P<.001), and 2.8 times more likely to complete appointment 4 (P<.001) compared to patients who did not log in. CONCLUSIONS HIV primary care appointment completion was higher when patients engaged with Healthvana’s digital platform. Digital technology interventions to ensure patients complete their scheduled HIV care appointments are imperative to curb the HIV epidemic.

ASAdam Carl Sukhija-Cohen
Adam Carl Sukhija-Cohen
MBMichael Foxworth Blasingame
Michael Foxworth Blasingame
HPHenna Patani
Henna Patani
MSMarie C.D. Stoner
Marie C.D. Stoner
ACAntón Castellanos-Usigli
Antón Castellanos-Usigli
AMAllysha C. Maragh-Bass
Allysha C. Maragh-Bass
Retention in pre-exposure prophylaxis (PrEP) care—defined as receiving a fourth PrEP prescription within 12 months of initiation—remains a major challenge for young adults and individuals minoritized by race and ethnicity in the United States (U.S.), particularly after disruptions in care from the Coronavirus Disease 2019 (COVID-19) pandemic. This study examined changes in PrEP retention before and after COVID-19 among clients ages 18–29 years at AIDS Healthcare Foundation (AHF) Wellness Center clinics across the U.S. We conducted a retrospective analysis of electronic health record (EHR) data from 6047 clients who initiated PrEP between 1 January 2018 and 15 March 2023. Retention was defined as receiving a fourth PrEP prescription within 12 months of initiation. Overall, PrEP initiation increased threefold post-COVID-19, but retention by the fourth prescription declined from 86.2% pre-COVID-19 to 62.6% post-COVID-19 (p < 0.001). Clients initiating PrEP post-COVID-19 had significantly lower odds of retention (odds ratio [OR] = 0.13; p < 0.001), suggesting these systemic disruptions reduced continuity of care. Additionally, clients who identify as non-White had lower retention odds compared to clients who identify as White post-COVID-19 (OR = 0.80; p = 0.003), indicating that racial/ethnic disparities in PrEP care persist beyond the pandemic’s impact. These findings highlight the need for targeted interventions to strengthen retention in PrEP care post-COVID-19.

14 March 2026 in Journal of Adolescent Health
Verified
Journal Article
Open access
ASAdam Carl Sukhija-Cohen
Adam Carl Sukhija-Cohen
AGAmandeep Kaur Grewal
Amandeep Kaur Grewal
JVJane Vu
Jane Vu
PKPragati Kenkare
Pragati Kenkare
ACAlger Baldwin Chapman
Alger Baldwin Chapman
SBSarina Kumari Behera
Sarina Kumari Behera
To determine if implementation of opt-out chlamydia testing increased diagnoses among female pediatric patients at the Palo Alto Medical Foundation in Northern California. We conducted a retrospective study of 21,660 active female patients aged 16-24 at 21 pediatric clinics. Chi-square tests with degrees of freedom (df) assessed changes preimplementation (2023) and postimplementation (2024) of opt-out testing and across demographic subgroups. Testing more than doubled, from 12.9% in 2023 to 31.7% in 2024 (χ2[df] = 1,089.5[1]; p < .001), with increases across all age, insurance, and racial/ethnic groups. Gains were largest among patients with private insurance and those identifying as Hispanic/Latino or non-Hispanic Asian. Although the proportion of diagnoses declined from 1.6% to 0.9% (χ2[df] = 5.4[1], = .02), the number of diagnoses rose from 22 to 30. Embedding opt-out testing in pediatric visits is a scalable strategy to advance sexually transmitted infection prevention goals.